Objective
The overall objective will be to create and mobilise an International network of high calibre centres around a strong European group of institutes selected for their appropriate expertises, to collect, amplify, characterise, standardise, authenticate, distribute and track, mammalian and other exotic viruses. The network of EVAg laboratories including 25 institutions represents an extensive range of virological disciplines. The architecture of the consortium is based on the association of capacities accessible to the partners but also to any end-users through the EVAg web-based catalogue. This concept has been elaborated and tested for its efficiency during the successful EVA project (FP7). The project will integrate more facilities dedicated to high risk pathogen (HRP) manipulation (1 in EVA, 13 in EVAg) The access to products derived from those HRP will be enhanced and for instance the production of diagnostic reagents will be facilitated. The new project will also provide access to high containment biosafety facilities to carry out in vivo studies of infectious disease using natural or models hosts, to look at prophylactic or therapeutic control measures and to develop materials for the evaluation of diagnostic tests, meaning an extensive capacity to service and to training. EVAg will also link up with other network-based virus-associated programmes that exist globally. However, looking further ahead, EVAg is conceived ultimately to be an open entity aiming at developing synergies and complementarity capabilities in such a way as to offer an improved access to researchers. This project will generate the largest collection of mammalian viruses in the world and move beyond the current state-of-the-art to provide an increasingly valuable resource and service to the world’s scientific community, including government health departments, higher education institutes, industry and, through information systems, the general public.
Fields of science
Call for proposal
H2020-INFRAIA-2014-2015
See other projects for this call
Funding Scheme
RIA - Research and Innovation actionCoordinator
13284 Marseille
France
Participants (25)
20359 Hamburg
SW1P 3JR London
Participation ended
53127 Bonn
LS2 7UE Leeds
4051 Basel
1000 Ljubljana
845 05 Bratislava
00149 Roma
13353 Berlin
3015 GD Rotterdam
2333 ZA Leiden
75654 Paris
75724 Paris Cedex 15
17493 Greifswald-insel Riems
GU24 0NF Woking
0001 Pretoria
2131 Sandringham
142782 Moskva
197376 St Petersburg
105064 Moscow
430071 Wuhan
2601 Acton Act
171 82 Solna
69227 Lyon
10117 Berlin